Anticoagulation strategies and difficulties in neonatal and paediatric extracorporeal membrane oxygenation (ECMO)

被引:25
作者
Stocker, Christian F. [1 ]
Horton, Stephen B. [2 ]
机构
[1] Queensland Childrens Hosp, Paediat Intens Care Med, Brisbane, Qld, Australia
[2] Royal Childrens Hosp, Paediat Perfus Unit, Melbourne, Vic, Australia
来源
PERFUSION-UK | 2016年 / 31卷 / 02期
关键词
ECMO; ECLS; complications; anticoagulation; neonatal; paediatric; PARTIAL THROMBOPLASTIN TIME; ACTIVATED CLOTTING TIME; FACTOR XA ASSAY; HEPARIN-THERAPY; COAGULATION; MANAGEMENT; CHILDREN; IMPACT;
D O I
10.1177/0267659115590626
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: The aim of this review is to highlight an emerging problem with anticoagulation-related complications in neonatal and paediatric ECMO, to explore for flaws in the currently recommended anticoagulation management responsible for these problems and to discuss possible strategies mitigating further escalation of the issue. Data Sources: Pertinent neonatal and paediatric literature on the topic of interest and international Extracorporeal Life Support Organisation (ELSO) registry data request. Conclusions: The international ELSO registry data reveals increasing rates of anticoagulation-related complications during neonatal and paediatric ECMO worldwide. The causes are multifactorial and the proposed solution to the problem is to match anticoagulation management to the pathophysiological complexity of haemostasis on ECMO.
引用
收藏
页码:95 / 102
页数:8
相关论文
共 35 条
[1]   Use of a novel anticoagulation strategy during ECMO in a pediatric population:: Single-center experience [J].
Agati, Salvatore ;
Ciccarello, Giuseppe ;
Salvo, Dario ;
Turla, Giancarlo ;
Uendar, Akif ;
Mignosa, Carmelo .
ASAIO JOURNAL, 2006, 52 (05) :513-516
[2]   Correlation of thromboelastography with standard tests of anticoagulation in paediatric patients receiving extracorporeal life support [J].
Alexander, D. C. ;
Butt, W. W. ;
Best, J. D. ;
Donath, S. M. ;
Monagle, P. T. ;
Shekerdemian, L. S. .
THROMBOSIS RESEARCH, 2010, 125 (05) :387-392
[3]   Anticoagulation for Pediatric Mechanical Circulatory Support [J].
Annich, Gail ;
Adachi, Iki .
PEDIATRIC CRITICAL CARE MEDICINE, 2013, 14 (05) :S37-S42
[4]  
Annich GM., 2012, ECMO Extracorporeal Cardiopulmonary Support in Critical Care, P75
[5]   Anticoagulation and pediatric extracorporeal membrane oxygenation: Impact of activated clotting time and heparin dose on survival [J].
Baird, Christopher W. ;
Zurakowski, David ;
Robinson, Barbara ;
Gandhi, Sanjiv ;
Burdis-Koch, Leighann ;
Tamblyn, Joseph ;
Munoz, Ricardo ;
Fortich, Karol ;
Pigula, Frank A. .
ANNALS OF THORACIC SURGERY, 2007, 83 (03) :912-920
[6]   The National Heart, Lung, and Blood Institute Pediatric Circulatory Support Program A Summary of the 5-Year Experience [J].
Baldwin, J. Timothy ;
Borovetz, Harvey S. ;
Duncan, Brian W. ;
Gartner, Mark J. ;
Jarvik, Robert K. ;
Weiss, William J. .
CIRCULATION, 2011, 123 (11) :1233-1240
[7]   PROSPECTIVE STUDY OF VALUE OF MONITORING HEPARIN TREATMENT WITH ACTIVATED PARTIAL THROMBOPLASTIN TIME [J].
BASU, D ;
CADE, J ;
GALLUS, A ;
HIRSH, J .
NEW ENGLAND JOURNAL OF MEDICINE, 1972, 287 (07) :324-+
[8]   Cell-based models of coagulation: A paradigm in evolution [J].
Becker, RC .
JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2005, 20 (01) :65-68
[9]   Variability in Anticoagulation Management of Patients on Extracorporeal Membrane Oxygenation: An International Survey [J].
Bembea, Melania M. ;
Annich, Gail ;
Rycus, Peter ;
Oldenburg, Gary ;
Berkowitz, Ivor ;
Pronovost, Peter .
PEDIATRIC CRITICAL CARE MEDICINE, 2013, 14 (02) :E77-E84
[10]   PREPARATION OF HEPARIN AND ITS USE IN THE 1ST CLINICAL CASES [J].
BEST, CH .
CIRCULATION, 1959, 19 (01) :79-86